Just diagnosed. Intermediate risk stage. I am concerned my PSA (0.7/3yrs) is not indicating true risk. Sister with breast, father melo. PNI in base core sample. 23andME says negative on BCRA1/2 (mpMRI coming. 2nd biopsy opinion coming).
It looks to me like i am trending more towards unfavourable due to some higher risk factors.
So not sure it matters now to get additional genomic tests in terms of treatment decision.
I also find that Polaris, Onco, Decipher show significant discordance between tests, with NCCN risk criteria. medpagetoday.com/meetingcov.... Not sure how to think about this.
Question now: is genomic evaluation potentially helpful given my particulars?
Should i get more than one or all three? Insurance coverage is don't care.
How does 23andME compare given result i have?
Thanks for any help, 45r
Written by
45RPM
To view profiles and participate in discussions please or .
23andME is crap, Color Genome Dx is much better (used by Johns Hopkins). They are germline tests.
The somatic tests (like Decipher or Prolaris) are not useful for you unless you are on the fence about active surveillance. It sounds like you are not, so such tests are a waste of money.
There are 2 types of genetic testing. One is a simple inexpensive saliva test; can get from color.com . The other is obtained from a biopsy tissue sample, sent to Foundation Medicine. May be covered by insurance. I first had the color test, then had the Foundation test after my prostate was removed. Both were positive for BRCA2+.
Thanks to these tests I was put on Olaparib, which has been very effective for me by keeping my PSA undetectable.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.